Clinical trial
SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has…
NCT00005030 · M.D. Anderson Cancer Center, Other · Withdrawn
Key facts
| NCT number | NCT00005030 |
|---|---|
| Title | SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver |
| Official title | A Phase IB Study of Oral Administration of SCH 66336 Preoperatively in Patients With Colorectal Carcinoma Metastatic to the Liver Scheduled for Exploratory Laparotomy and/or Resection |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Colorectal Cancer, Metastatic Cancer |
| Intervention type | Drug, Procedure |
| Interventions | SCH 66336, conventional surgery |
| Enrollment | 0 |
| Start date | Sep 29, 1999 |
| Primary completion | Sep 1, 2000 |
| Completion | Sep 1, 2000 |
| First posted | Jun 4, 2004 |
| Last update posted | Nov 14, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: